Jonathan Solomon
Chief Executive Officer at BIOMX INC.
Net worth: 11 250 $ as of 2024-03-30
Profile
Jonathan Eithan Solomon is the founder.
He founded Proclara Biosciences, Inc. in 2006 and served as the Chief Executive Officer & Media Relations Contact in 2015.
Currently, he holds the position of Chief Executive Officer & Director at BiomX, Inc. since 2019, Chief Executive Officer & Director at BiomX Ltd.
since 2017, and Director at Solomon Holdings Ltd.
since 2009.
Previously, he worked as a Principal at Medtronic Corp.
Mr. Solomon's education includes a graduate degree from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem, and an MBA from Harvard Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOMX INC.
0.05% | 2023-12-10 | 25,000 ( 0.05% ) | 11 250 $ | 2024-03-30 |
Jonathan Solomon active positions
Companies | Position | Start |
---|---|---|
BIOMX INC. | Chief Executive Officer | 2019-10-27 |
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Director/Board Member | 2013-03-06 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Executive Officer | 2017-04-30 |
Former positions of Jonathan Solomon
Companies | Position | End |
---|---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Founder | 2015-11-30 |
Medtronic Corp. | Corporate Officer/Principal | - |
Training of Jonathan Solomon
Tel-Aviv University | Graduate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOMX INC. | Health Technology |
Private companies | 4 |
---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Finance |
Medtronic Corp. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Stock Market
- Insiders
- Jonathan Solomon